FI952250A0 - 5,6-Dihydro-4H-thieno [3,4-c] pyrrole derivatives, their preparation and therapeutic use - Google Patents

5,6-Dihydro-4H-thieno [3,4-c] pyrrole derivatives, their preparation and therapeutic use

Info

Publication number
FI952250A0
FI952250A0 FI952250A FI952250A FI952250A0 FI 952250 A0 FI952250 A0 FI 952250A0 FI 952250 A FI952250 A FI 952250A FI 952250 A FI952250 A FI 952250A FI 952250 A0 FI952250 A0 FI 952250A0
Authority
FI
Finland
Prior art keywords
thieno
dihydro
preparation
therapeutic use
pyrrole derivatives
Prior art date
Application number
FI952250A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI952250A (en
Inventor
Zurita Manuel Bedoya
Martin Juan Antonio Diaz
Sol Moreno Gregorio De
Perez Ulpiano Martin Escudero
Bargueno Maria Dolores Jimenez
Ferrer Magali Romanach
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI952250A0 publication Critical patent/FI952250A0/en
Publication of FI952250A publication Critical patent/FI952250A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI952250A 1994-05-10 1995-05-09 5,6-dihydro-4H-thieno / 3,4-c / pyrrole derivatives, preparation and therapeutic use thereof FI952250A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405716A FR2719844B1 (en) 1994-05-10 1994-05-10 5,6-dihydro-4h-thieno [3,4-c] pyrrole derivatives, their preparation and their therapeutic use.

Publications (2)

Publication Number Publication Date
FI952250A0 true FI952250A0 (en) 1995-05-09
FI952250A FI952250A (en) 1995-11-11

Family

ID=9463059

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952250A FI952250A (en) 1994-05-10 1995-05-09 5,6-dihydro-4H-thieno / 3,4-c / pyrrole derivatives, preparation and therapeutic use thereof

Country Status (17)

Country Link
EP (1) EP0682028A1 (en)
JP (1) JPH0853457A (en)
KR (1) KR950032205A (en)
CN (1) CN1117970A (en)
AU (1) AU1793395A (en)
CA (1) CA2148880A1 (en)
CZ (1) CZ119695A3 (en)
FI (1) FI952250A (en)
FR (1) FR2719844B1 (en)
HU (1) HUT72667A (en)
IL (1) IL113673A0 (en)
NO (1) NO951812L (en)
NZ (1) NZ272090A (en)
PL (1) PL308516A1 (en)
RU (1) RU95107154A (en)
SK (1) SK59795A3 (en)
ZA (1) ZA953749B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19514579A1 (en) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Use of alpha-1-olone agonists for the treatment of urinary incontinence
FR2733750B1 (en) * 1995-05-03 1997-06-13 Synthelabo DERIVATIVES OF GAMMA-OXO-ALPHA- (PHENYLMETHYL) -5,6- DIHYDRO-4H-THIENO (3,4-C) PYRROLE-5-BUTANOIQUE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
WO1999057131A1 (en) 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8529546D0 (en) * 1985-11-30 1986-01-08 Beecham Group Plc Compounds
EP0600973A1 (en) * 1991-08-27 1994-06-15 The Upjohn Company A method for treatment of metabolic disorders and metabolism
EP0599697A1 (en) * 1992-11-24 1994-06-01 Synthelabo Pyrrole derivatives, their preparation and application in therapy

Also Published As

Publication number Publication date
EP0682028A1 (en) 1995-11-15
NO951812L (en) 1995-11-13
PL308516A1 (en) 1995-11-13
CA2148880A1 (en) 1995-11-11
SK59795A3 (en) 1995-12-06
JPH0853457A (en) 1996-02-27
NZ272090A (en) 1996-03-26
KR950032205A (en) 1995-12-20
CN1117970A (en) 1996-03-06
RU95107154A (en) 1997-03-20
HUT72667A (en) 1996-05-28
FI952250A (en) 1995-11-11
ZA953749B (en) 1996-04-02
NO951812D0 (en) 1995-05-09
IL113673A0 (en) 1995-08-31
CZ119695A3 (en) 1995-11-15
AU1793395A (en) 1995-11-16
FR2719844B1 (en) 1996-06-07
FR2719844A1 (en) 1995-11-17

Similar Documents

Publication Publication Date Title
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
EE9800459A (en) Spiro-piperidine derivatives and their use as therapeutic agents
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
IL116139A0 (en) Pyrrole derivatives their preparation and use
FI944600A0 (en) Imidazol-4-ylpiperidine derivatives, their preparation and their use in therapy
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
EE9600172A (en) Purin-6-one derivatives, their preparation method, use in the preparation of medicaments and medicaments
EE03830B1 (en) 1H-pyrido [3,4-b] indole-4-carboxamide derivatives, processes for their preparation and use in therapy
EE9700288A (en) Azacycloalkane derivatives, their preparation and use in therapy
IS1913B (en) Tricyclic 5,6-dihydro-9H-pyrazolo [3,4c] -1,2,4-triazolo [4,3a] pyridine, their use and pharmaceutical composition
EE9900218A (en) 1,4-Diazabicyclo [2.2.2] oct-2-ylmethyl benzoate derivatives, their preparation and their use in therapy
DK1000063T3 (en) 4-oxo-3,5-dihydro-4H-pyridazine [4,5-b] indole-1-acetamide derivatives, their preparation and therapeutic use thereof
EE03691B1 (en) 1,2,3,4-Tetrahydrobenzofuro [3,4-c] pyridine derivatives, process for their preparation, use, pharmaceutical composition and process for their preparation
EG21121A (en) 13 Substituted milbemycin derivatives their preparation and use
FI940186A0 (en) 9H-Imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their use in therapy
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
EE9900414A (en) 2,3-dihydrofuro [3,2-b] pyridine derivatives, their preparation and use in therapy
EE9800333A (en) Novel furanarylmethylidene derivatives, methods for their preparation and use in therapy
EE9800174A (en) Use of tricyclic derivatives of 1,4-dihydro-1,4-dioxo-1H-naphthalene, new compounds and their use in therapy
EE200000207A (en) 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, their preparation and therapeutic use
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
AU5183193A (en) Pyrrole derivatives, their preparation and their therapeutic use
FI952250A0 (en) 5,6-Dihydro-4H-thieno [3,4-c] pyrrole derivatives, their preparation and therapeutic use
FR2765582B1 (en) 3-ALKYL-1,9-DIHYDRO-2H-PYRIDO [2,3-B] INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION
FR2761068B1 (en) PIPERAZIN-4-YLTHIENO [3,2-C] PYRIDIN-4-YL-2- CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION